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Abstract
This year, The Cochrane Collaboration reached its 20th anniversary. It has played a pivotal role in the scientific
development of systematic reviewing and in the development of review methods to synthesize research evidence,
primarily from randomized trials, to answer questions about the effects of healthcare interventions. We introduce a
series of articles, which form this special issue describing the development of systematic review methods within
The Cochrane Collaboration. We also discuss the impact of Cochrane Review methods, and acknowledge the
breadth and depth of methods development within The Cochrane Collaboration as part of the wider context of
evidence synthesis. We conclude by considering the future development of methods for Cochrane Reviews.
Archie Cochrane’s vision of the future in 1972
‘(The pathologist)..will be replaced by the medical
scientist who will measure the effectiveness and
efficiency of therapy in the hospital and the
community and in conjunction with social scientists
to assess the adequacy of community care...........I hope
clinicians in the future will abandon the pursuit of the
“margin of the impossible” and settle for “reasonable
probability”.’AL Cochrane (1972) Effectiveness and
Efficiency: Random Reflections on Health Services The
Nuffield Provincial Hospitals Trust [1].
Introduction
The Cochrane Collaboration, a research synthesis
organization, is celebrating its 20th Anniversary in 2013.
Whilst taking stock of its achievements, it is identifying
areas for improvement and development as pressures
continue for the synthesis of the proliferation of re-
search, in order to aid healthcare decision making [2].
Key to the development of the rigorous review model
established by The Cochrane Collaboration is the
methodological work that has been undertaken along-
side review production. This has resulted in the
formation of sixteen international methods specific
networks developing methods for application in Cochrane
Reviews.
Background
Archie Cochrane, director of the MRC Epidemiology
Unit in Cardiff, Wales, UK, at the time of writing the
above evaluation of the National Health Service (UK),
clearly articulated the need for applied scientific evi-
dence over the expert opinion of clinicians [1]. In 1979
he suggested that ‘It is surely a great criticism of our
profession that we have not organized a critical sum-
mary, by specialty or subspecialty, adapted periodically
of all relevant randomized controlled trials’ [2]. This
spurred Sir Iain Chalmers [3] and others to take the
steps needed to set up, in 1993, The Cochrane Collabor-
ation, which began with a meeting of 77 people from
nine different countries. Since then, The Cochrane
Collaboration has grown substantially. It is now an inter-
national network of more than 28,000 voluntary contrib-
utors from over 120 countries [4], which publishes full
systematic reviews and their protocols in The Cochrane
Database of Systematic Reviews (CDSR). This has
published reviews online since 1996, via The Cochrane
Library. The CDSR currently includes more than 2,300
review protocols and more than 5,600 full reviews have
been published. The Library also contains, amongst
other databases CENTRAL, the world’s largest reposi-
tory of records for randomized trials, with more than
700,000 as of September 2013.
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The Cochrane Collaboration has been at the forefront
of systematic review methodology, pioneering a rigorous
approach that standardizes a highly structured system-
atic review model. Key elements of the model are trans-
parency and reproducibility of research methods. These
include title registration, publication of a protocol and
periodic updating of the subsequent published system-
atic review. The Cochrane Collaboration has drawn in
an international spectrum of individuals to support and
develop the methods for systematic reviews over this
time. This article provides an overview of this work and
the major contributions that The Cochrane Collabor-
ation has made to systematic review methodology over
the last 20 years. We introduce a series of articles that
present and discuss key methodological developments
within Cochrane, such as the development of the ‘Risk
of bias’ tool [5] and ‘Summary of findings’ tables [6]
which are now regularly being seen in systematic re-
views. The articles also scan the methodological horizon
to identify important developments for future Cochrane
Reviews and systematic review methods more generally.
In recent years, The Cochrane Collaboration has
broadened its original scope from the effects of interven-
tions to address other types of uncertainty, with the
appearance of systematic reviews of diagnostic test ac-
curacy and a pilot project to examine the feasibility of
reviews of prognosis. Methodological developments have
also supported the appropriate use of non-randomized
designs to assess adverse effects of interventions, and
the enhancement of intervention reviews with brief eco-
nomic summaries. Other developments include the
introduction of statistical concepts such as network
meta-analysis to allow indirect comparisons of multiple
interventions. The Cochrane Collaboration is also devel-
oping expertise around the handling of intervention
complexity in Cochrane Reviews, as well as incorporat-
ing qualitative evidence syntheses, to provide additional
explanatory data on healthcare interventions.
The series of articles in this special issue highlights the
current and future contribution of The Cochrane Col-
laboration to the overall quality, standing and rigor of
systematic review methodology in the wider inter-
national community. It also highlights the contribution
of Cochrane methods and the Cochrane Review model
to the scientific discipline of systematic reviews.
A core component of methods development within The
Cochrane Collaboration is the international methods spe-
cific networks referred to as Methods Groups. These
groups are unique within the global evidence synthesis
community, providing a rich resource of committed ex-
perts in systematic review methodology working across
many disciplines. The flourishing of these groups over the
years is indicative of an emergent academic discipline
recognizing the requirement for robust methods to
synthesize evidence for healthcare. These groups are re-
sponsible for contributing to the chapters in the Cochrane
Handbook of Systematic Reviews of Interventions [7]. The
Groups specialize in particular aspects of systematic re-
view methodology, including: searching for studies, statis-
tics and meta-analysis (MA) including prospective MA
and individual participant data MA, assessing bias, use of
non-randomized designs, the incorporation of qualitative
and economic data, the applicability and interpretation of
the findings of systematic reviews, patient reported out-
comes, equity issues, screening and diagnostic tests, and
prognosis. More recently, Methods Groups have formed
specializing in the methods of indirect comparisons and
network meta-analysis, and in the setting of priorities for
systematic reviews and other research.
Since The Cochrane Collaboration was established
two decades ago, the task of preparing and maintaining
systematic reviews for a range of health and social
topics, utilizing a wide range of approaches has ex-
panded considerably. There are now several examples
of other organizations producing evidenced based syn-
thesis, including the Agency for Healthcare Research
and Quality (ARHQ) in the US and the Joanna Briggs
Institute based in Australia. The Campbell Collaboration,
which works in partnership with The Cochrane Collabor-
ation, produces systematic reviews on the effects of inter-
ventions in crime and justice, education, international
development, and social welfare. The Centre for Reviews
and Dissemination (CRD) part of the National Institute of
Health Research (NIHR) in the UK, is one of a number of
producers of systematic reviews and health technology
assessments for the NIHR, but has also developed the
international prospective register of systematic reviews
(PROSPERO) [8] and continues its work to produce
The Database of Abstracts of Reviews of Effects. Also
based in the UK is the Evidence for Policy and Practice
Information and Co-ordinating Centre that produces sys-
tematic reviews and develops review methods in social sci-
ence and public policy. The Cochrane Collaboration has
many ties with these organizations and members that
work across these different agencies. It also has partner-
ships with organizations which cite, use or collaborate on
systematic reviews and other initiatives. These include, for
example, the World Health Organization [9], guideline de-
velopers such as the National Institute of Health and Clin-
ical Excellence (NICE) in the UK [10] and the Guideline
International Network (G-I-N), as well as other national
agencies such as the Institute of Medicine in the US.
The impact of 20 years of Cochrane methodology
Cochrane Reviews have made valuable contributions to
healthcare research, practice and policy across a wide
range of topics, for example by furthering our knowledge
of falls prevention in older people, stroke, tobacco
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addiction, preventing and treating childhood obesity,
and managing chronic diseases such as diabetes and em-
physema. Not only have Cochrane Reviews established
the role of some interventions in the management of
health problems, they have also challenged the place of
others. There is an expectation that new research should
be informed by previous research, and, for example, The
Lancet now asks authors to report the results of new re-
search within the context of existing systematic review
evidence [11].
However, quantifying the influence of Cochrane Reviews
and methods is not easy. One crude metric is the impact
factor of the CDSR, which is 5.785, ranking it 11th of 151
journals in the Medicine, General and Internal category. A
recent evaluation by Shen and colleagues of the production
and utilization of Cochrane Reviews, showed the rapid
growth in the average annual output of reviews and the
high citation rate of Cochrane Reviews in high income
countries (for example, England, Australia, Canada and
USA). However, they also identified the lack of production
and the under utilization of Cochrane Reviews in other
parts of the world, and proposed more applicable evidence
production such as public health reviews [12]. The
Cochrane Collaboration has recently established a satellite
for its Public Health Review Group in India. The use
of Cochrane evidence in clinical guidelines and other
evidence-based recommendations is another guide to the
impact of The Cochrane Collaboration. A recent study
found that, as of July 2013, 1,158 Cochrane Reviews from
47 Cochrane Review Groups have been used to inform 238
clinical guidelines and other evidence-based recommenda-
tions from the Scottish Intercollegiate Guidelines Network
(24 reviews), National Institute of Health and Care Excel-
lence guidelines (115 reviews), and the World Health
Organization (99 reviews) [13].
More specifically for impact of The Cochrane Collabor-
ation on the methods of systematic reviews, the Cochrane
Handbook for Systematic Reviews of Interventions has been
cited over 6,600 times [14]. An annual journal supplement
to The Cochrane Library (http://www.thecochranelibrary.
com/view/0/CochraneMethods.html) keeps members of
The Cochrane Collaboration apprised of the methodo-
logical work being undertaken within Cochrane, as well as
commenting on other relevant published methodological
work. Furthermore, Table 1 highlights some key contribu-
tions members of Cochrane Methods Groups have made
to Cochrane Reviews. These include major methodo-
logical developments such as the early development of
the Cochrane Handbook, bias assessment, the quantifi-
cation of heterogeneity to measure the degree of incon-
sistency in the primary studies [15] and the more
recent introduction of the ‘Summary of findings’
table based on GRADE considerations [16]. Add-
itional historical information of the development of
The Cochrane Collaboration and its Methods Groups
can be found on The Cochrane Collaborations web-
site (http://www.cochrane.org/about-us/history), and
the annual Cochrane Colloquium is an important
Table 1 Key methodological developments in Cochrane Reviews
2014 ‘Risk of bias’ tool extension for non standard randomized studies (for example, crossover and cluster trials) and non-randomized studies
2012 Introduction of the Methodological Expectations of Cochrane Intervention Reviews (MECIR) standards
2011 Launch of the Cochrane Methods Innovation fund
2008 Release of version 5 of RevMan incorporating ‘Risk of Bias’ tool
Grade profiler software (GRADEpro) introduced for ‘Summary of findings’ tables in RevMan
2002 I2 statistics measuring inconsistency in meta-analysis [22]
1996 Launch of The Cochrane Library launched by Update Software incorporating The Cochrane Database of Systematic Reviews,
The Database of Abstracts of Reviews of Effectiveness, The Cochrane Controlled Trials Register and The Cochrane Review Methodology Database
Bias assessment classification system introduced for allocation concealment [27]
1994 First publication demonstration of The Cochrane Database of Systematic Reviews
Publication of the first edition of the Cochrane Handbook [26]
Registration of the first Methods Groups: Statistical MG and Individual Patient Data MG
1993 Formal launch of the Cochrane Collaboration at the first Cochrane Colloquium in Oxford, UK
Release of version 1 of Review Manager (RevMan)
1992 Formal launch of the first UK Cochrane Centre in Oxford
1988 Publication of the first in a series of overviews (meta-analyses) in the British Journal of Obstetrics and Gynaecology
1976 Term ‘meta-analysis’ first introduced [25]
1972 Publication of Archie Cochrane’s Effectiveness and Efficiency: Random Reflections on Health Services which first drew attention to the collective
ignorance about the effects of health care [1]
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scientific platform, with oral and poster presentations
showing the breadth of scientific developments in sys-
tematic review methodology [17].
A notable recent example of impact of both new meth-
odology and the Cochrane Review comes from the work
of the Cochrane Acute Respiratory Infections Group and
others on the Cochrane Review of neuraminidase inhibi-
tors (including Tamiflu) for influenza [18]. This illustrates
the challenges of implementing standard methodological
expectations when synthesizing data from a substantial
unpublished evidence base. By abandoning journal articles
in favor of full technical reports as their primary sources
of data, the authors have had to capture information from
thousands of pages of information in order to assess and
collect the outcome data they need for their analyses. Set
in the context of conflicting national regulatory and drug
licensing processes, the review provides a reference point
for how systematic reviews may need to draw on new
types of evidence, and the methodological tools that will
be needed to do this in years to come.
Article series
The articles in this special issue of Systematic Reviews il-
lustrate the overall development and impact of research
evidence synthesis in The Cochrane Collaboration over
the last 20 years. The series begins with a personal reflec-
tion from Andy Oxman, who was instrumental in the
early development of methodology in The Cochrane Col-
laboration and set out challenges for Cochrane [19] over
ten years ago. In reflecting and updating these challenges
and how they might be met, he notes that the Collabor-
ation has come a long way, but that ‘a huge amount of
work remains to be done’. He suggests a need to broaden
the review structure to address different types of review
questions, a wider use of non-randomized studies, the
comparison of multiple interventions and the develop-
ment of efficient updating strategies.
A collection of articles then focuses on principal
methods and underpinning principles of systematic re-
views, beginning with the identification and retrieval of
studies where new developments in information are
already leading to substantial changes. These include
new techniques in semantic analysis, text mining and
data linkage that identify the ‘meaning’ as oppose to just
the ‘presence’ of the term, as well as developments in
identifying unpublished data. Another article discusses
the assessment of study bias and the development of the
Cochrane ‘Risk of bias’ tool in 2008. This tool is being
revised to improve its utility and reliability and exten-
sions will support the assessment of bias in other types
of research. In regard to meta-analysis methods, statis-
tical inference and the presentation of the findings of re-
views, articles from the Statistical Methods Group and
the Applicability and Recommendations Methods Group
show substantial developments in, for example, assessing
statistical heterogeneity and the use of GRADE criteria
to produce ‘Summary of findings’ tables.
Other articles in this series illustrate the diversity of
evidence that is being incorporated into Cochrane Re-
views. One of these discusses the introduction of reviews
of diagnostic test accuracy (rather than the effects on
health outcomes of particular tests), which have started
to pave the way for Cochrane to include other types of
systematic review alongside its more traditional reviews
of the effects of interventions. The other articles focus
on the development and implementation of methods to
assess ‘cost’ in systematic reviews, which are being devel-
oped by the Campbell and Cochrane Economic Methods
Group, and the challenges of incorporating qualitative
research to enhance understanding of the wider context
of healthcare interventions.
Across The Cochrane Collaboration, other specific
methods networks are examining the appraisal and
reporting of adverse effects, the use of non-randomized
designs including the assessment of bias in these studies,
the development of methods to prioritize and update re-
views, and the consideration of equity in both the con-
duct and the interpretation of reviews.
The future of methods development in Cochrane
The ongoing drive for The Cochrane Collaboration is to
ensure that it produces high quality, relevant and up to
date systematic reviews. In keeping with the need to
continue to improve the quality of reporting [20-23],
The Cochrane Collaboration has produced a set of stan-
dards. These standards [24] cover the conduct and
reporting of reviews, including the reporting of protocols
and the updating of reviews.
The Cochrane Collaboration is committed to pioneering
research that will lead to further improvements in the
methods used for Cochrane Reviews. As an example, the
Cochrane Methods Innovation Fund has supported six
methods related projects since 2012. These projects are in-
vestigating priority topics for Cochrane and include:
methods of searching for unpublished trials, extensions to
the Cochrane ‘Risk of bias’ tool to assess risk of bias in
randomized trials with non-parallel-group designs and
non-randomized studies, enhancing the acceptance and
implementation of ‘Summary of findings’ tables, the as-
sessment of complex interventions, addressing missing
trial participant data and methods (network meta-analysis)
for comparing multiple interventions.
A fundamental feature of Cochrane Reviews since the
start of the Collaboration has been the requirement to
update them periodically. Twenty years on, methodology
research is seeking to establish the longevity of the clin-
ical relevance of Cochrane Reviews, taking account of
changes in methodology as well as additional evidence.
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This will help to ensure that the quality of each Cochrane
Review improves alongside the incorporation of more re-
cent studies [25]. This is a fundamental area of policy, and
methodological development, not least because nearly
70% of Cochrane Reviews had not been updated in the
last two years in 2012 [26]. Future research is needed to
determine the feasibility and efficiency of updating and
prioritization strategies, including statistical techniques
[27,28], so that the necessary guidance can be prepared.
The need for systematic reviews to inform decision
making in health and social care will remain into the
foreseeable future [29]. This highlights the ongoing
importance of the collaborative effort of The Cochrane
Collaboration amongst others to continue to use sound
methods to aggregate the ever-increasing number of
new studies. Technological as well as methodological
progress is key to advancing the aggregation and
dissemination of systematic review evidence [30]. Some
challenges for systematic reviews arise from successes in
improving access to the potentially eligible studies
including prospective registration of randomized trials
[31], the ongoing push for greater availability of pub-
lished as well as unpublished study reports [32] and the
need to update reviews to inform and interpret new
research will require robust methods, and resources.
The capacity to identify and appraise the underlying
research and to systematically synthesize the evidence
will continue to be challenging for organizations such as
The Cochrane Collaboration.
Conclusion
This article outlined the breadth and diversity of system-
atic review methods that are being incorporated in
Cochrane Reviews. These, and other, systematic reviews
need to encompass a range of evidential data [33], to de-
termine treatment effectiveness and to explain, inform,
contextualize and triangulate the findings. Thus it seems
appropriate in this 20th year of systematic review devel-
opment that The Cochrane Collaboration’s contribution
to this emergent academic discipline [34] is established.
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